What Works For Anxiety Disorders-Anti-Anxiety Drugs

SSRI Discontinuation Syndrome

SSRI discontinuation syndrome

When was the SSRI discontinuation syndrome first recognized?
Reports began to emerge soon after the SSRIs were introduced in the late 1980s.
How common is it? The incidence and prevalence of this syndrome is …

XEPLION® (paliperidone palmitate)

European Commission Approves XEPLION® for Treatment of Schizophrenia
Beerse, Belgium (March 9, 2011) — Janssen-Cilag International NV today announced that XEPLION® (paliperidone palmitate), a once monthly, long-acting injectable, antipsychotic, has received approval from the European Commission …

Withdrawal effects

Withdrawal effects
How can I tell the difference between withdrawal problems and relapse?
There are three ways to tell if symptoms are the result of withdrawal, according to one expert, David Healy, who applied it to SSRIs …

Trazodone Hydrochloride 50mg Capsules

Trazodone Hydrochloride 50mg Capsules
SUMMARY OF PRODUCT CHARACTERISTICS

NAME OF THE MEDICINAL PRODUCT: Trazodone Hydrochloride 50mg Capsules

QUALITATIVE AND QUANTITATIVE COMPOSITION

Trazodone Hydrochloride 50mg (For the full list of excipients, see section 6.1)

PHARMACEUTICAL FORM

Capsules Hard gelatin, size 3, green-violet coloured …

Psychotropic Medication Use among Adolescents

Psychotropic Medication Use among Adolescents: United States, 2005–2010
Key findings
Data from the National Health and Nutrition Examination Survey

Approximately 6.0% of U.S. adolescents aged 12–19 reported psychotropic drug use in the past month.
The use of antidepressants (3.2%) …